Premenstrual syndrome and self-medication with opioids

Area of Science:

• Neuroscience
• Psychiatry
• Pharmacology

Background:

• Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) are common conditions affecting women's health.
• The pathophysiology of PMS/PMDD is not fully understood, but involves complex interactions with neurobiological systems.
• Opioid receptors are implicated in mood regulation and pain perception, suggesting a potential role in PMS/PMDD.

Observation:

• A patient undergoing opioid substitution treatment for opioid use disorder presented with premenstrual complaints.
• The patient reported using heroin to self-medicate premenstrual symptoms.
• This case highlights a potential link between opioid pathways and the manifestation of premenstrual symptoms.

Findings:

• A review of PMS/PMDD diagnosis, etiology, and the relationship with opioid receptors was conducted.
• The patient's opioid substitution treatment involved methadone.
• Increasing the methadone dose during the premenstrual period led to substantial clinical improvement in the patient's symptoms.

Implications:

• This case suggests that modulating the endogenous opioid system may be a viable therapeutic strategy for PMS/PMDD.
• Further research into the role of opioid receptors in PMS/PMDD is warranted.
• Opioid substitution therapy might offer a dual benefit for patients with opioid use disorder and premenstrual symptomatology.